Abstract
Neurocysticercosis (NCC), infection of the central nervous system by the larval stage of the pork tapeworm Taenia solium, is the most common parasitic disease of the human brain and the leading preventable cause of acquired epilepsy worldwide. Endemic across Latin America, sub-Saharan Africa, and much of Asia, it has become an increasingly frequent imported disease in high-income countries through migration and travel. Clinical expression ranges from silent calcified granulomas to life-threatening cysticercotic
encephalitis, ventricular obstruction, and stroke, depending on parasite burden, evolutionary stage, anatomic compartment, and host immune response.
References
1. White AC Jr. Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis, and management. Annu Rev Med. 2000;51:187–206.
2. Del Brutto OH, et al. Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the IDSA and ASTMH. Clin Infect Dis. 2018;66(8):e49–e75.
3. Del Brutto OH, Rajshekhar V, White AC Jr, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology. 2001;57:177–183.
4. Garcia HH, Gonzalez AE, Evans CAW, Gilman RH; Cysticercosis Working Group in Peru. Taenia solium cysticercosis. Lancet. 2003;362:547 556.
5. Nash TE, et al. Treatment of neurocysticercosis: current status and future research
needs. Neurology. 2006;67:1120–1127.